These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20948752)

  • 1. Impulse control disorders in Parkinson's disease.
    Stacy M
    F1000 Med Rep; 2009 May; 1():. PubMed ID: 20948752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
    Wolters ECh; van der Werf YD; van den Heuvel OA
    J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
    Giovannoni G; O'Sullivan JD; Turner K; Manson AJ; Lees AJ
    J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):423-8. PubMed ID: 10727476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.
    Pettorruso M; Fasano A; De Risio L; Ricciardi L; Di Nicola M; Martinotti G; Janiri L; Bentivoglio AR
    J Neurol Sci; 2016 Mar; 362():344-7. PubMed ID: 26944176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impulse control behaviors associated with antiparkinsonian medications].
    Depierreux-Lahaye F; Crémers J; Skawiniak E; Parmentier E; Delvaux V; Garraux G
    Rev Med Liege; 2013; 68(5-6):221-5. PubMed ID: 23888568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced impulse control disorders in Parkinson's disease.
    Reiff J; Jost WH
    J Neurol; 2011 May; 258(Suppl 2):S323-7. PubMed ID: 21560063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorders in patients with Parkinson's disease.
    Gescheidt T; Bares M
    Acta Neurol Belg; 2011 Mar; 111(1):3-9. PubMed ID: 21510226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report.
    Guedes BF; Gonçalves MR; Cury RG
    Dement Neuropsychol; 2016; 10(2):148-151. PubMed ID: 29213446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse-control disorders in Parkinson's disease.
    Ferrara JM; Stacy M
    CNS Spectr; 2008 Aug; 13(8):690-8. PubMed ID: 18704024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
    Fenu S; Wardas J; Morelli M
    Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-related impulse control and repetitive behaviors in Parkinson's disease.
    Voon V; Potenza MN; Thomsen T
    Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine agonists and therapy compliance.
    Grosset D
    Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
    Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F
    J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
    Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
    Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.
    Cabrini S; Baratti M; Bonfà F; Cabri G; Uber E; Avanzi M
    Neurol Sci; 2009 Aug; 30(4):307-13. PubMed ID: 19513585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulse control disorders in Parkinson's disease: Review of pathophysiology, epidemiology, clinical features, management, and future challenges.
    Bhattacharjee S
    Neurol India; 2018; 66(4):967-975. PubMed ID: 30038082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulse control disorders in Parkinson disease: A cross-sectional study in Morocco.
    El Otmani H; Mouni FZ; Abdulhakeem Z; Attar Z; Rashad L; Saali I; El Moutawakil B; Rafai MA; Slassi I; Nadifi S
    Rev Neurol (Paris); 2019 Apr; 175(4):233-237. PubMed ID: 30935674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.